Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT

被引：0
|
作者：
Delmas, P. D.
Bauer, D.
Black, D.
Boonen, S. R.
Cosman, F.
Eastell, R.
机构：
[1] Univ Lyon 1, Dept Med, F-69365 Lyon, France
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Louvain, Ctr Metab Bone Dis, Louvain, Belgium
[5] Helen Hayes Hosp, Dept Med, W Haverstraw, NY USA
[6] No Gen Hosp, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [21] Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once-Yearly ZOL: HORIZON-PFT Extension Study
    Eastell, Richard
    Boonen, Steven
    Cosman, Felicia
    Reid, Ian R.
    Palermo, Lisa
    Cummings, Steven R.
    Black, Dennis M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (03) : 483 - 487
  • [22] Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON pivotal fracture trial.
    Black, D. M.
    Boonen, S.
    Cauley, J.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Rosario-Jansen, T.
    Caminis, J.
    Zhang, J.
    Hu, H.
    Cummings, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S305 - S305
  • [23] Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON Pivotal Fracture Trial.
    Black, D. M.
    Boonen, S.
    Cauley, J.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Rosario-Jansen, T.
    Caminis, J.
    Zhang, J.
    Hu, H.
    Cummings, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S16 - S16
  • [24] Effect of once-yearly zoledronic acid 5 mg on 'Super Six' non-vertebral fractures
    Black, D. M.
    Eastell, R.
    Cosman, F.
    Man, Z.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    BONE, 2009, 44 (02) : S429 - S429
  • [25] Effect of previous bisphosphonate use on response to zoledronic acid: Results from the HORIZON-PFT study
    Lippuner, Kurt
    Eastel, Richard
    Reid, Fan
    Benhamou, Claude-Laurent
    Recknor, Chris
    Ish-Shalom, Sophia
    Bianchi, Gerolaino
    Black, Dennis
    Mesenbrink, Peter
    Eriksen, Erik Fink
    Delmas, Pierre D.
    BONE, 2008, 42 : S77 - S77
  • [26] BONE MINERAL DENSITY AFTER HIP FRACTURE: VARIATIONS IN RESPONSE TO ONCE-YEARLY IV ZOLEDRONIC ACID 5 MG
    Magaziner, Jay
    Orwig, Denise
    Lyles, Kenneth W.
    Nordsletten, Lars
    Boonen, Steven
    Adachi, Jonathan
    Colon-Emeric, Cathleen
    Bucci-Rechtweg, Christina
    Mesenbrink, Peter
    Pieper, Carl
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S213 - S213
  • [27] Effect of zoledronic acid 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-pft
    Cauley, J.
    Black, D.
    Boonen, S.
    Cummings, S.
    Delmas, P.
    Eriksen, E. F.
    Hu, H.
    Eastell, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [28] The effects of zoledronic acid 5 mg once-yearly on bone remodeling and structure in osteoporotic women are consistent across age
    Recker, R. R.
    Delmas, P.
    Reid, I.
    Boonen, S.
    Halse, J.
    Garcia, P.
    Supronik, J.
    Lewiecki, M.
    Ochoa, L.
    Miller, P.
    Hartl, F.
    Gasse, J. A.
    Mesenbrink, P.
    Hu, H.
    Eriksen, E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S129 - S129
  • [29] Effect of zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-PFT
    Cauley, Jane A.
    Black, Dennis
    Boonen, Steven R.
    Cummings, Steven
    Delmas, Pierre
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S232 - S232
  • [30] Effect of Zoledronic Acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFT
    Cauley, J.
    Black, D.
    Boonen, S.
    Cummings, S.
    Delmas, P.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S26 - S26
12345